Results 21 to 30 of about 3,528,989 (183)

Targeted Radionuclide Therapy: A Theranostic Approach to Cancer Therapy. [PDF]

open access: yesClin J Oncol Nurs
Targeted radionuclide therapy is a rapidly progressing therapy that offers an individualized approach to cancer treatment by using radioisotopes (radiation) that are created specifically to help visualize with imaging and/or.
Davis ME, Longing A.
europepmc   +4 more sources

Application of the Linear-Quadratic model to targeted radionuclide therapy [PDF]

open access: yes, 2011
PhDThe principal aim of this work was to test the hypothesis that the Linear-Quadratic (LQ) model of cell survival, developed for external beam radiotherapy (EBRT), could be extended to targeted radionuclide therapy (TRT) in order to predict dose ...
Murray, Iain
core   +4 more sources

Targeted radionuclide therapies for pancreatic cancer [PDF]

open access: yesCancer Gene Therapy, 2015
Pancreatic malignancies, the fourth leading cause of cancer deaths, have an aggressive behavior with poor prognosis, resulting in a 5-year survival rate of only 4%. It is typically a silent malignancy until patients develop metastatic disease. Targeted radionuclide therapies of cancer such as radiolabeled peptides, which bind to the receptors ...
M, Shah   +5 more
openaire   +2 more sources

Targeting Melanin in Melanoma with Radionuclide Therapy

open access: yesInternational Journal of Molecular Sciences, 2022
Nearly 100,000 individuals are expected to be diagnosed with melanoma in the United States in 2022. Treatment options for late-stage metastatic disease up until the 2010s were few and offered only slight improvement to the overall survival. The introduction of B-RAF inhibitors and anti-CTLA4 and anti-PD-1/PD-L1 immunotherapies into standard of care ...
Kevin J. H. Allen   +3 more
openaire   +2 more sources

What is the role of the bystander response in radionuclide therapies?

open access: yesFrontiers in Oncology, 2013
Radionuclide therapy for cancer is undergoing a renaissance, with a wide range of radionuclide and clinical delivery systems currently under investigation.
Darren eBrady   +2 more
doaj   +1 more source

Combination Therapies with PRRT

open access: yesPharmaceuticals, 2021
Peptide receptor radionuclide therapy (PRRT) is a successful targeted radionuclide therapy in neuroendocrine tumors (NETs). However, complete responses remain elusive.
Anna Yordanova, Hojjat Ahmadzadehfar
doaj   +1 more source

Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review

open access: yesPharmaceutics, 2023
The actinium-225 (225Ac) radioisotope exhibits highly attractive nuclear properties for application in radionuclide therapy. However, the 225Ac radionuclide presents multiple daughter nuclides in its decay chain, which can escape the targeted site ...
Sipho Mdanda   +4 more
doaj   +1 more source

Combination Strategies to Improve Targeted Radionuclide Therapy [PDF]

open access: yesJournal of Nuclear Medicine, 2020
In recent years, targeted radionuclide therapy (TRT) has emerged as a promising strategy for cancer treatment. In contrast to conventional radiotherapy, TRT delivers ionizing radiation to tumors in a targeted manner, reducing the dose that healthy tissues are exposed to.
Chan, T   +3 more
openaire   +3 more sources

Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy. [PDF]

open access: yesMol Cancer Ther
Abstract Protein tyrosine kinase 7 (PTK7), a receptor found in tumor-initiating cells, is expressed in various malignancies, including ovarian cancer. While PTK7 has been explored as a target for antibody-drug conjugates, this study is the first to investigate its potential for targeted radionuclide therapy.
Lindland K   +7 more
europepmc   +4 more sources

Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

open access: yesFrontiers in Medicine, 2021
Samarium-153 (153Sm) is a highly interesting radionuclide within the field of targeted radionuclide therapy because of its favorable decay characteristics.
Michiel Van de Voorde   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy